Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

McGill University

$17,500.00

The Impact of Subthalamic Nucleus Deep Brain Stimulation on Apathy in Parkinson's Disease

FY 2016-17

Summary
Parkinson's disease (PD) patients whose motor symptoms can no longer be controlled with medication often undergo a surgical procedure called deep brain stimulation of the subthalamic nucleus (STN DBS). In STN DBS, an electrode is implanted in the STN normalizing its signal, which is hyperactive and disorganized in PD patients. STN DBS is an effective treatment that dramatically reduces PD-related motor symptoms, medication-induced motor complications and improves PD patients' quality of life (QoL). However, it can be accompanied by changes in mood, such as apathy, which manifests as an overall lack of motivation and interest. Importantly, there is evidence that apathy can hinder the beneficial effects that STN DBS has on QoL in PD. In order to combat the negative impact that apathy after STN DBS can have on QoL we need to better understand the factors that contribute to apathy. The STN is made up of regions that are related to different functions. While the target of the electrode is the motor regions of the STN, it is possible for the electrode to be placed in the limbic-associative areas of the STN. Stimulation of these areas may lead to mood problem such as apathy. We would like to determine whether the location of the stimulating electrodes within the STN is related the occurrence of apathy. Additionally, as motor symptoms improve, the amount of dopaminergic medication is often reduced after STN DBS. There is evidence that dopaminergic medication can improve apathy symptoms, therefore we would also like to determine whether a reduction in dopaminergic medication is related to apathy. The finding from this research have the potential to improve patient management after STN DBS and also better inform us about the brain basis of apathy.
Program
Master's Award: Canada Graduate Scholarships
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367324
Name
Saadat Nazanin
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Impact of Subthalamic Nucleus Deep Brain Stimulation on Apathy in Parkinson's Disease
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apathy; Dopamine Medication Dosage; Electrode Localization; Neuroimaging; Non-Motor Symptoms; Parkinson'S Disease; Quality Of Life; Subthalamic Nucleus Deep Brain Stimulation
Abstract
Parkinson's disease (PD) patients whose motor symptoms can no longer be controlled with medication often undergo a surgical procedure called deep brain stimulation of the subthalamic nucleus (STN DBS). In STN DBS, an electrode is implanted in the STN normalizing its signal, which is hyperactive and disorganized in PD patients. STN DBS is an effective treatment that dramatically reduces PD-related motor symptoms, medication-induced motor complications and improves PD patients' quality of life (QoL). However, it can be accompanied by changes in mood, such as apathy, which manifests as an overall lack of motivation and interest. Importantly, there is evidence that apathy can hinder the beneficial effects that STN DBS has on QoL in PD. In order to combat the negative impact that apathy after STN DBS can have on QoL we need to better understand the factors that contribute to apathy. The STN is made up of regions that are related to different functions. While the target of the electrode is the motor regions of the STN, it is possible for the electrode to be placed in the limbic-associative areas of the STN. Stimulation of these areas may lead to mood problem such as apathy. We would like to determine whether the location of the stimulating electrodes within the STN is related the occurrence of apathy. Additionally, as motor symptoms improve, the amount of dopaminergic medication is often reduced after STN DBS. There is evidence that dopaminergic medication can improve apathy symptoms, therefore we would also like to determine whether a reduction in dopaminergic medication is related to apathy. The finding from this research have the potential to improve patient management after STN DBS and also better inform us about the brain basis of apathy.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Saadat, Nazanin
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~